Drug Type Bispecific antibody |
Synonyms PD-L1/Gas6 trap 双功能抗体 |
Target |
Action inhibitors |
Mechanism GAS6 inhibitors(Growth arrest-specific protein 6 inhibitors), PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | China | 01 Jan 2022 |






